课题基金 / 基金详情

XENOBIOTIC BIOTRANSFORMATION IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE

XENOBIOTIC BIOTRANSFORMATION IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE
非酒精性脂肪肝病儿童的异生生物转化
批准号:
7951010
负责人:
JOEL Edward LAVINE
金额:
$0.74万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

JOEL Edward LAVINE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The principle objective is to compare the activity of phase I and II enzymes in xenobiotic metabolism in adolescents with or without non-alcoholic fatty liver disease. Specifically, we would compare CYP 1A2, CYP2D6, CYP3A, glucuronyl-transferase (UGT) and sulfono-transferase (ST) activity between these two populations. Other objectives include: To estimate caffeine clearance using a single plasma sample, and CYP 1A2 activity based on urine collection; To determine the utility of saliva collection in determining absorption rate of caffeine and acetaminophen; To determine the utility of saliva collection in determining acetaminophen metabolism
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
XENOBIOTIC BIOTRANSFORMATION IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE
CLINICAL TRIAL: TONIC - TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN
CLINICAL TRIAL: PIOGLITAZONE VS VITAMIN E VS PLACEBO FOR NONALCOHOLIC STEATOHEPA
CLINICAL TRIAL: NON-ALCOHOLIC STEATOHEPATITIS CLINICAL RESEARCH NETWORK
海外基金